Leustatin Related Clinical Trials
2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) [Active, not recruiting]
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab [Active, not recruiting]
CLARITY - Safety and Efficacy of Oral Cladribine in Subjects With Relapsing-Remitting MS [Active, not recruiting]
Clarity Extension Study [Enrolling by invitation]
Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Active, not recruiting]
Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis [Completed]
Phase II Cladribine Add-on to Inteferon-Beta (IFN-b) Therapy in MS Subjects With Active Disease [Recruiting]
Oral Cladribine in Early Multiple Sclerosis (MS) [Not yet recruiting]
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia [Recruiting]
2CDA With Rituximab in Hairy Cell Leukemia [Recruiting]
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia [Active, not recruiting]
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With Chronic Lymphocytic Leukemia [Active, not recruiting]
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma [Recruiting]
Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Recruiting]
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, or Relapsed B-Cell Non-Hodgkin Lymphoma [Recruiting]
Cladribine in Patients With Mantle Cell Lymphoma [Active, not recruiting]
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia [Completed]
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Recruiting]
Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma [Completed]
A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-Cell Chronic Lymphocytic Leukemia [Not yet recruiting]
Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy [Active, not recruiting]
A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia [Recruiting]
BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia [Active, not recruiting]
Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath [Completed]
Combination Chemotherapy Regimens Followed by CNS Radiation Therapy, Thioguanine, and Cytarabine in Treating Young Patients With Standard-Risk or High-Risk Acute Myeloid Leukemia [Recruiting]
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Completed]
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Active, not recruiting]
Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Completed]
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) [Recruiting]
German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults [Recruiting]
Clofarabine in Chronic Lymphocytic Leukemia [Active, not recruiting]
Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia [Recruiting]
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents [Recruiting]
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia [Recruiting]
Low-Dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia [Recruiting]
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Recruiting]
A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia [Completed]
|
